Mary C. Sano
#128,376
Most Influential Person Now
Mary C. Sano's AcademicInfluence.com Rankings
Mary C. Sanopsychology Degrees
Psychology
#2683
World Rank
#3094
Historical Rank
Neuropsychology
#70
World Rank
#73
Historical Rank
Mary C. Sanophilosophy Degrees
Philosophy
#6122
World Rank
#9096
Historical Rank
Logic
#3311
World Rank
#4447
Historical Rank
Download Badge
Psychology Philosophy
Mary C. Sano's Degrees
- PhD Psychology University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Mary C. Sano Influential?
(Suggest an Edit or Addition)Mary C. Sano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. (1997) (2355)
- Vitamin E and donepezil for the treatment of mild cognitive impairment. (2005) (1712)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease (1997) (1127)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. (2003) (920)
- Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. (2004) (917)
- Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial (2000) (905)
- Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. (1994) (846)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope (1997) (588)
- Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. (1996) (568)
- High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. (2008) (506)
- Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus (2018) (476)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study (2008) (469)
- Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. (2014) (455)
- Neuropsychological detection and characterization of preclinical Alzheimer's disease (1995) (428)
- Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. (1992) (387)
- Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. (2006) (359)
- Predicting time to nursing home care and death in individuals with Alzheimer disease. (1997) (346)
- The course of psychopathologic features in mild to moderate Alzheimer disease. (1997) (338)
- Cognitive function in nondemented older women who took estrogen after menopause (1998) (336)
- Risk of dementia after stroke in a hospitalized cohort (1994) (321)
- Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. (2000) (320)
- Clinical Dementia Rating training and reliability in multicenter studies (1997) (315)
- Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology (2003) (312)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Frequency and clinical determinants of dementia after ischemic stroke (2000) (306)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Predictors of disease course in patients with probable Alzheimer's disease (1987) (274)
- Dementia after stroke (1992) (273)
- Age at onset of Alzheimer's disease (1994) (266)
- Alzheimer's disease after remote head injury: an incidence study. (1997) (266)
- Incidence of Dementia After Ischemic Stroke: Results of a Longitudinal Study (2002) (266)
- A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease (2011) (263)
- Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. (1997) (245)
- Effect of literacy on neuropsychological test performance in nondemented, education-matched elders (1999) (245)
- A randomized controlled trial of prednisone in Alzheimer’s disease (2000) (240)
- Modified Mini-Mental State Examination: Validity and Reliability (1987) (236)
- Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease (1994) (234)
- A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. (2000) (230)
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition (2014) (228)
- Cognitive test performance among nondemented elderly African Americans and whites (1998) (220)
- Treatment of agitation in AD (2000) (218)
- Dichloroacetate causes toxic neuropathy in MELAS (2006) (211)
- Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. (2011) (209)
- Clinical determinants of dememtia related to stroke (1993) (209)
- Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery: A Randomized Clinical Trial (2017) (205)
- Quality of Life in Patients with Alzheimer's Disease as Reported by Patient Proxies (1996) (200)
- Neuropsychological differences between late-onset and recurrent geriatric major depression. (2005) (198)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Neuropsychological characteristics of preclinical dementia in Parkinson's disease (1995) (192)
- Recovery of cognitive function after stroke. (1996) (176)
- Preventing Alzheimer’s Disease (2008) (172)
- Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. (2008) (162)
- A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease (1996) (159)
- Assessing patient dependence in Alzheimer's disease. (1994) (159)
- Measurement and prediction of functional capacity in Alzheimer's disease (1990) (158)
- Postmenopausal estrogen use and Parkinson's disease with and without dementia (1998) (156)
- Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. (1991) (155)
- ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials (2006) (141)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Health Literacy and Cognitive Performance in Older Adults (2009) (138)
- The relationship of serotonin to depression in Parkinson's disease (1988) (136)
- Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype (2011) (133)
- Assessing Patterns of Agitation in Alzheimer's Disease Patients with the Cohen‐Mansfield Agitation Inventory (1997) (129)
- Current Alzheimer's disease clinical trials: Methods and placebo outcomes (2009) (126)
- Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. (1994) (126)
- Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. (1991) (121)
- Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury (2014) (120)
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions (2014) (119)
- Treatment of Alzheimer's disease. (1999) (117)
- A phase 3 trial of IV immunoglobulin for Alzheimer disease (2017) (115)
- Neuropsychologic impairment in early HIV infection. A risk factor for work disability. (1995) (113)
- Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old (2006) (113)
- Incidence of new-onset seizures in mild to moderate Alzheimer disease. (2012) (112)
- Economic considerations in the management of Alzheimer’s disease (2006) (112)
- The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease (1997) (112)
- Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. (2003) (112)
- Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease (2006) (111)
- Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. (1991) (108)
- Cross-cultural neuropsychological assessment: a comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults. (1997) (107)
- Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals (2011) (106)
- Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. (1993) (105)
- Clinical and biochemical correlates of bradyphrenia in Parkinson's disease (1987) (102)
- Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment (1993) (102)
- Mortality in patients with dementia after ischemic stroke (2002) (101)
- Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis (2015) (98)
- Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study (2015) (98)
- Coexisting dementia and depression in Parkinson's disease. (1989) (96)
- Realistic expectations for treatment success in Alzheimer's disease. (2006) (95)
- The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable (2018) (90)
- Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. (1992) (90)
- Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons (1993) (89)
- Clinical Characteristics and Longitudinal Changes of Informal Cost of Alzheimer's Disease in the Community (2006) (89)
- Nursing home placement is related to dementia progression (1999) (88)
- Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. (1993) (87)
- The validity of new memory complaints in the elderly. (1997) (87)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. (2002) (86)
- Long‐term administration of oral physostigmine in Alzheimer's disease (1988) (85)
- Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma. (2015) (85)
- Cognitive performance in hypotensive persons with spinal cord injury (2010) (82)
- Effects of oral physostigmine in Alzheimer's disease (1987) (82)
- Estrogen to treat Alzheimer’s disease: Too little, too late? (2000) (82)
- Normative data for a brief neuropsychological battery administered to English- and Spanish-speaking community-dwelling elders (1998) (79)
- The cognitive syndrome of vascular dementia: implications for clinical trials. (1999) (77)
- Current treatment and recent clinical research in Alzheimer's disease. (2010) (75)
- Maternally inherited encephalopathy associated with a single‐base insertion in the mitochondrial tRNATrp gene (1997) (75)
- Patient Dependence and Longitudinal Changes in Costs of Care in Alzheimer’s Disease (2008) (74)
- A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimer's Disease Clinical Trials: Overview and General Results (1997) (71)
- Cerebral lactic acidosis correlates with neurological impairment in MELAS (2004) (69)
- The effects of galantamine treatment on caregiver time in Alzheimer's disease (2003) (69)
- Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy (2016) (67)
- A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. (2003) (67)
- Clinical features and genetics of myoclonic epilepsy with ragged red fibers. (2002) (67)
- Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes (2014) (66)
- 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (65)
- Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. (1996) (65)
- ADCS Prevention Instrument Project: Overview and Initial Results (2006) (64)
- Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease (2013) (64)
- Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease (2014) (63)
- The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease (2008) (63)
- Dependence as a unifying construct in defining Alzheimer's disease severity (2010) (62)
- Participation in clinical trials and long-term outcomes in Alzheimer's disease (1997) (61)
- Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future (2007) (61)
- The Impact of Nutrition on Cognition in the Elderly (2007) (61)
- Protean phenotypic features of the A3243G mitochondrial DNA mutation. (2009) (60)
- A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study (2018) (59)
- Depression and Parkinson's disease. (1987) (59)
- Application of a growth curve approach to modeling the progression of Alzheimer's disease. (1996) (59)
- Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit (2012) (58)
- Health‐Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment (2013) (58)
- Dementia as a predictor of adverse outcomes following stroke: an evaluation of diagnostic methods. (1998) (57)
- Longitudinal study of quality of life in people with advanced Alzheimer's disease. (2001) (56)
- Estrogen levels do not correlate with improvement in cognition. (2003) (56)
- Functional Neural Correlates of Attentional Deficits in Amnestic Mild Cognitive Impairment (2013) (56)
- Home Health and Informal Care Utilization and Costs Over Time in Alzheimer's Disease (2008) (54)
- Ischemic stroke and depression. (2003) (53)
- Adding Delayed Recall to the Alzheimer Disease Assessment Scale is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease (2011) (52)
- Clinical features associated with costs in early AD (2006) (51)
- A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium (2008) (50)
- An update on treatment and prevention strategies for Alzheimer’s disease (2009) (49)
- A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. (1995) (48)
- Reliability of Monitoring the Clinical Dementia Rating in Multicenter Clinical Trials (2004) (46)
- Cognitive Profile of Chronic Kidney Disease and Hemodialysis Patients without Dementia (2010) (46)
- Can Intraoperative Processed EEG Predict Postoperative Cognitive Dysfunction in the Elderly? (2015) (46)
- Developing a national strategy to prevent dementia: Leon Thal Symposium 2009 (2010) (45)
- Clinical trial designs for demonstrating disease-course-altering effects in dementia. (1998) (45)
- Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease Severity (1993) (45)
- Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo (2009) (44)
- Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001 (2019) (43)
- Hourly care received by people with Alzheimer's disease: results from an urban, community survey. (1998) (42)
- Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data (2014) (42)
- Vitamin E in aging persons with Down syndrome (2016) (42)
- Neuropsychological Changes in a Prospectively Followed Cohort of Homosexual and Bisexual Men With and Without HIV Infection (1995) (41)
- Cardiac risk factors and potential treatments in Alzheimer's disease (2006) (41)
- Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. (1993) (41)
- Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort (2011) (41)
- Diagnostic criteria for apathy in neurocognitive disorders (2021) (40)
- Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease (2000) (40)
- Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. (1996) (40)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure (2020) (38)
- Synaptic protein deficits are associated with dementia irrespective of extreme old age (2012) (38)
- Increased Presence of Cognitive Impairment in Hemodialysis Patients in the Absence of Neurological Events (2011) (38)
- Cross-Domain Variability of Cognitive Performance in Very Old Nursing Home Residents and Community Dwellers: Relationship to Functional Status (2005) (37)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. (2013) (33)
- Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. (1995) (33)
- Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer Disease (2012) (32)
- Physical activity and risk of cognitive impairment among oldest-old women. (2014) (32)
- Blast Exposure, White Matter Integrity, and Cognitive Function in Iraq and Afghanistan Combat Veterans (2017) (31)
- Cognition in non-demented diabetic older adults. (2012) (31)
- A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition (2014) (31)
- ADCS Prevention Instrument Project: Pharmacoeconomics: Assessing Health-related Resource Use Among Healthy Elderly (2006) (30)
- A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease (1990) (30)
- Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. (2019) (30)
- Noncholinergic treatment options for Alzheimer's disease. (2003) (29)
- First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. (1998) (29)
- Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition. (2020) (29)
- The Spanish Instrument Protocol: Design and Implementation of a Study to Evaluate Treatment Efficacy Instruments for Spanish‐Speaking Patients with Alzheimer's Disease (1997) (28)
- Do Stress Markers and Anesthetic Technique Predict Delirium in the Elderly? (2014) (28)
- Reducing case ascertainment costs in U.S. population studies of Alzheimer’s disease, dementia, and cognitive impairment—Part 1 (2011) (28)
- Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies (2008) (28)
- The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults. (2017) (28)
- Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia (1998) (28)
- Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes (2014) (28)
- Neuropsychological Testing in the Diagnosis of Dementia (2006) (28)
- Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials (2015) (27)
- A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics (2008) (27)
- Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes (2017) (26)
- Haptoglobin 1-1 Genotype Is Associated With Poorer Cognitive Functioning in the Elderly With Type 2 Diabetes (2013) (26)
- The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes (2014) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Evaluating cognition in an elderly cohort via telephone assessment (2010) (25)
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
- Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? (2008) (25)
- Erratum: Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity (Alzheimer Disease and Associated Disorders (1993) 7 (22-32)) (1993) (25)
- Undertreatment of patients with Alzheimer’s disease in an elderly United States population (2005) (24)
- Does Postoperative Cognitive Decline Result in New Disability After Surgery? (2020) (24)
- Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adults. (2005) (24)
- The Relationship of Plasma Aβ Levels to Dementia in Aging Individuals With Down Syndrome (2009) (24)
- Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease (2013) (24)
- Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment (2010) (24)
- Posttraumatic stress disorder and total amyloid burden and amyloid-β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders (2019) (24)
- MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s disease pathogenesis (2020) (24)
- CR1 and the “Vanishing Amyloid” Hypothesis of Alzheimer’s Disease (2013) (23)
- Use of Medicare and Department of Veterans Affairs Health Care by Veterans with Dementia: A Longitudinal Analysis (2009) (23)
- Impact of APOE epsilon4 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians. (2009) (23)
- Human plasma biomarker responses to inhalational general anaesthesia without surgery. (2020) (23)
- Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease. (2019) (23)
- Asthma Control and Cognitive Function in a Cohort of Elderly Adults (2015) (22)
- Assessment of Aging Individuals with Down Syndrome in Clinical Trials: Results of Baseline Measures (2005) (22)
- Understanding the role of estrogen on cognition and dementia. (2000) (22)
- Women's cognitive and affective health and neuropsychiatry. (2006) (22)
- No Long-Term Effect of Behavioral Treatment on Psychotropic Drug Use for Agitation in Alzheimer's Disease Patients (2002) (21)
- S5-01-05: Multi-center, randomized, double-blind, placebo-controlled trial of Simvastatin to slow the progression of Alzheimer's disease (2008) (21)
- Reduced cortical thickness in World Trade Center responders with cognitive impairment (2020) (21)
- Profiles of Alzheimer's disease-related pathology in an aging urban population sample in India. (2011) (21)
- The net effect of alternative allocation ratios on recruitment time and trial cost (2009) (21)
- Performance of Spanish-speaking community-dwelling elders in the United States on the Uniform Data Set (2014) (20)
- Clock-drawing in neurological disorders. (1989) (20)
- Depression in Parkinson's disease: a biochemical model. (1990) (20)
- Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica. (2011) (20)
- Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease. (2021) (20)
- ADCS Prevention Instrument Project: Quality of Life Assessment (QOL) (2006) (19)
- Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife (2020) (19)
- Sex differences in cognition (2016) (19)
- Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs (1993) (19)
- Analysis of longitudinal data in an Alzheimer's disease clinical trial. (2000) (19)
- The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial (2019) (19)
- Pilot Study to Show the Feasibility of a Multicenter Trial of Home-based Assessment of People Over 75 Years Old (2010) (18)
- Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women (2016) (18)
- Simple reaction time as a measure of global attention in Alzheimer's disease (1995) (18)
- Characterizing Cognitive Deficits and Dementia in an Aging Urban Population in India (2012) (18)
- Current Concepts in the Prevention of Alzheimer's Disease (2003) (18)
- Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes (2016) (18)
- Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data (2017) (18)
- Developing Dementia Prevention Trials: Baseline Report of the Home-Based Assessment Study (2013) (17)
- The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes (2014) (17)
- Potential contribution of the Alzheimer׳s disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly (2016) (17)
- Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force. (2018) (17)
- Rationale and Design of a Multicenter Study of Selegiline and α-Tocopherol in the Treatment of Alzheimer Disease Using Novel Clinical Outcomes (1996) (16)
- Multicenter Evaluation of New Instruments for Alzheimer's Disease Clinical Trials: Summary of Results (1997) (16)
- Decreased Motor Function Is Associated with Poorer Cognitive Function in Elderly with Type 2 Diabetes (2014) (16)
- Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population. (2016) (16)
- NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables (2009) (15)
- Subjective cognitive complaints in patients undergoing major non-cardiac surgery: a prospective single centre cohort trial. (2019) (15)
- A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. (1996) (15)
- Alzheimer disease: Solanezumab—prospects for meaningful interventions in AD? (2015) (15)
- The Neuropsychological Performance of Nondemented Puerto Rican Nonagenarians (2009) (15)
- Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes (2018) (14)
- Spanish Instrument Protocol: New Treatment Efficacy Instruments for Spanish-speaking Patients in Alzheimer Disease Clinical Trials (2006) (14)
- Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial (2018) (14)
- C-reactive protein and familial risk for dementia (2012) (14)
- Longitudinal Medication Usage in Alzheimer Disease Patients (2010) (14)
- Measuring informed consent capacity in an Alzheimer's disease clinical trial (2016) (13)
- The costs and social burdens of Alzheimer disease: what can and should be done? (1997) (13)
- (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease. (2018) (13)
- Studies on new, centrally active and reversible acetylcholinesterase inhibitors (1990) (13)
- Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition (2003) (13)
- Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study (2016) (13)
- Assessment of cognition in advanced AD: The test for severe impairment (1999) (12)
- Why They Stay: Understanding Research Participant Retention in Studies of Aging, Cognitive Impairment and Dementia. (2014) (12)
- Multidisciplinary baseline assessment of gay men with and without HIV infection: III. neurological and neuropsychological findings. (1991) (12)
- Cognitive impairment and World Trade Centre-related exposures (2021) (12)
- Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer’s Disease: The TEAM-AD VA Cooperative Study (2018) (12)
- Bridging from clinical endpoints to estimates of treatment value for external decision makers (2009) (11)
- Tritiated imipramine binding. A peripheral marker for serotonin in Parkinson's disease. (1991) (11)
- Depressive Symptoms Are Associated with Cognitive Function in the Elderly with Type 2 Diabetes (2018) (11)
- Deterioration in Motor Function Over Time in Older Adults With Type 2 Diabetes is Associated with Accelerated Cognitive Decline. (2020) (10)
- Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairment (2021) (10)
- Cognitive performance of older adults in a specialized diabetes clinic (2017) (10)
- Delineating the Trajectory of Cognitive Recovery From General Anesthesia in Older Adults: Design and Rationale of the TORIE (Trajectory of Recovery in the Elderly) Project (2017) (10)
- A Comparison of Clinical Outcome and Survival in Various Forms of Alzheimer’s Disease (1992) (10)
- Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trial (2018) (10)
- Genome-wide association study and functional validation implicates JADE1 in tauopathy (2021) (10)
- Prevention of Alzheimer’s disease: Where we stand (2002) (10)
- Neuropsychological changes in a prospectively followed cohort of intravenous drug users with and without HIV (1996) (10)
- Utilization of Antihypertensives, Antidepressants, Antipsychotics, and Hormones in Alzheimer Disease (2011) (9)
- ADCS Prevention Instrument Project: Development of a Brief Verbal Memory Test for Primary Prevention Clinical Trials (2006) (9)
- A Workshop on Cognitive Aging and Impairment in the 9/11-Exposed Population (2021) (9)
- Increase in Number of Depression Symptoms Over Time is Related to Worse Cognitive Outcomes in Older Adults With Type 2 Diabetes. (2020) (9)
- Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals (2011) (9)
- Resting state functional connectivity in early post-anesthesia recovery is characterized by globally reduced anticorrelations (2019) (8)
- Design Considerations for Mobile Health Applications Targeting Older Adults. (2020) (8)
- Economic effect of cholinesterase inhibitor therapy: implications for managed care. (2004) (8)
- A double‐blind placebo‐controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design (2020) (8)
- Tarenflurbil: mechanisms and myths. (2010) (8)
- Do dietary antioxidants prevent Alzheimer's disease? (2002) (8)
- Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes (2017) (8)
- Demographic, Health, and Exposure Risks Associated With Cognitive Loss, Alzheimer's Disease and Other Dementias in US Military Veterans (2021) (8)
- Specific Dimensions of Depression Have Different Associations With Cognitive Decline in Older Adults With Type 2 Diabetes (2021) (8)
- Cardiovascular risk and memory in non-demented elderly women (2010) (8)
- Reduced cortical thickness in World Trade Center responders with cognitive impairment (2020) (8)
- Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells (2021) (8)
- Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA (2021) (7)
- Heterogeneity and prognosis in dementia of the Alzheimer type. (1985) (7)
- Design and implementation of a multicenter trial of vitamin E in aging individuals with Down syndrome (2005) (7)
- Depression and anxiety symptoms are related to pain and frailty but not cognition or delirium in older surgical patients (2020) (7)
- The Economics of Caring for Individuals with Alzheimer’s Disease (2013) (7)
- White Matter Connectivity in Incident Mild Cognitive Impairment: A Diffusion Spectrum Imaging Study of World Trade Center Responders at Midlife (2021) (7)
- A clinicopathological correlation study of cognitive status and senile plaques and neurofibrillary tangles in clinically well‐characterized individuals of extreme old age (2008) (6)
- Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
- Statistical treatment of withdrawal in trials of anti-dementia drugs – Authors' reply (2008) (6)
- Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease (2018) (6)
- Psychogeriatrics in a world with COVID-19 (2020) (6)
- Midlife interventions are critical in prevention, delay, or improvement of Alzheimer’s disease and vascular cognitive impairment and dementia (2017) (6)
- Priorities for research consortia on Alzheimer's disease (2010) (6)
- Recruiting US Chinese Elders Into Clinical Research for Dementia (2016) (6)
- DETAILS OF THE NEW ALZHEIMER’S ASSOCIATION BEST CLINICAL PRACTICE GUIDELINES FOR THE EVALUATION OF NEURODEGENERATIVE COGNITIVE BEHAVIORAL SYNDROMES, ALZHEIMER’S DISEASE AND DEMENTIAS IN THE UNITED STATES (2018) (6)
- Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003) (2016) (6)
- Predictors of disease course in patients with probable Alzheimerʼs disease (1988) (6)
- Stability in BMI over time is associated with a better cognitive trajectory in older adults (2022) (6)
- Comparing Advance Care Planning in Young-Onset Dementia in the USA vs Belgium: Challenges Partly Related to Societal Context. (2020) (6)
- Detecting Cognitive Impairment and Dementia in the Emergency Department: A Scoping Review. (2022) (5)
- The stability of neuropsychological test performance in a group of parenteral drug users. (1992) (5)
- Neuropsychological consequences of sickle cell disease (1996) (5)
- Cognitive performance in community-dwelling English- and Spanish-speaking seniors. (2009) (5)
- Intellectual assessment of young adult chronic patients. (1983) (5)
- Challenges in international clinical trials to delay early symptomatic Alzheimer's disease (2013) (5)
- Cognition may be related to arterial pulsatility index in HD patients. (2014) (5)
- Is postoperative cognitive decline clinically relevant? (2010) (5)
- Transient changes in white matter microstructure during general anesthesia (2021) (5)
- The determination of clinically meaningful cognitive decline: development and use of an alternative method. (1995) (5)
- The effect of simvastatin on cerebrospinal fluid levels of apolipoprotein E in patients with alzheimer's disease (1995) (4)
- CR 1 and the “ Vanishing Amyloid ” Hypothesis of Alzheimer ’ s Disease (2013) (4)
- "Estrogen replacement therapy for treatment of mild to moderate disease: A randomized controlled trial": Errata. (2000) (4)
- Alzheimer disease cooperative study (ADCS) home based assessment: Designing trials with new technology (2011) (4)
- Neuropsychological Test Performance in Cognitively Normal Spanish-speaking Nonagenarians with Little Education (2016) (4)
- Elderly Latino community members make an educational video: an academic-community collaboration to promote memory evaluations (2018) (4)
- Comparison of medical conditions and neurological examination in early Alzheimer's disease and normal elderly. (1992) (4)
- A Guide to Diagnosis of Alzheimer's Disease (2004) (4)
- Using Computers to Understand Attention in the Elderly (1988) (4)
- A randomized clinical trial to evaluate home-based assessment of people over 75 years old (2019) (4)
- Cognitive test battery for evaluating elderly Chinese Americans (2018) (4)
- Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training. (2019) (4)
- Tacrine and nursing home placement (1997) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- NON-AMNESTIC DEFICIT CHARACTERIZES THE COGNITIVE PROFILE IN DIABETES: RESULTS FROM NATIONAL ALZHEIMER'S COORDINATING CENTER'S UNIFORM DATA SET (NACC UDS) (2017) (3)
- S3-02-01 ADCS homocysteine trial (2007) (3)
- Associations of hemoglobin A1c with cognition reduced for long diabetes duration (2019) (3)
- Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease (2021) (3)
- Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale (2013) (3)
- Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1‐1 phenotype with cognitive function in older individuals with type 2 diabetes (2016) (3)
- Dimebon®: A Clinically Promising Drug for Alzheimer's Disease, Regulates Amyloid-Beta Metabolism in Cultured Cells, In Isolated Nerve Terminals, and In the Interstitial Fluid of the Living Rodent Brain (2009) (3)
- Discordant transcriptional signatures of mitochondrial genes in Parkinson’s disease human myeloid cells (2020) (3)
- Decision making concerning brain donation in Alzheimer’s research among research participants and their families (2015) (3)
- A cortical thinning signature to identify World Trade Center responders with possible dementia (2021) (3)
- Stability in BMI over time is associated with a better cognitive trajectory in older adults (2021) (3)
- ICAD 2010: detection may hold the key to treatment (2010) (3)
- (−)-Phenserine and Inhibiting Apoptosis: In Pursuit of a Novel Intervention for Alzheimer’s Disease (2018) (3)
- Short-term computerized cognitive training does not improve cognition compared to an active control in non-demented adults aged 80 years and above (2020) (3)
- Agitation in Cognitive Disorders: Use of the National Alzheimer’s Coordinating Center Uniform Data Set (NACC‐UDS) to Evaluate the International Psychogeriatric Association Definition. (2022) (3)
- Filipino Multicomponent Intervention to Maintain Cognitive Performance in High-Risk Population (FINOMAIN): Study Protocol for a Cluster Randomized Controlled Trial (2021) (2)
- OPTIMIZING MEASUREMENT OF AGITATION AND AGGRESSION IN DEMENTIA (2017) (2)
- Dimebon in Alzheimer's disease: Summary and contrast of three efficacy trials (2012) (2)
- Satisfaction of elderly research volunteers with home-based clinical trial participation (2013) (2)
- Florbetapir scanning excludes Alzheimer's disease in a retired NFL player with delayed cognitive impairment (2013) (2)
- P4-334: Eighteen-month data from an open-label extension of a one-year controlled trial of dimebon in patients with mild-to-moderate Alzheimer's disease (2008) (2)
- Subtle neuropsychological changes in HIV+ gay men. (1990) (2)
- Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study (2021) (2)
- Prediction of disability-free survival in healthy older people (2022) (2)
- BARRIERS TO COGNITIVE EVALUATIONS AMONG ELDERLY LATINOS: USING COMMUNITY-BASED PARTICIPATORY RESEARCH TO CREATE HEALTH EDUCATION VIDEOS (2016) (2)
- Emergency Department Communication in Persons Living With Dementia and Care Partners: A Scoping Review. (2022) (2)
- Cognitive effects of estrogens in women with cardiac disease: what we do not know. (2002) (2)
- Ttp488: From futile to fast track (2015) (2)
- Does Computerized Cognitive Training Improve Diabetes Self-Management and Cognition? A Randomized Control Trial of Middle-Aged and Older Veterans with Type 2 Diabetes. (2022) (2)
- Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition. (2023) (2)
- Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older Adults (2021) (2)
- Outcomes and clinical correlates of Alzheimer's disease patients with "silent" stroke. (1992) (1)
- Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator (2023) (1)
- Longitudinal medication usage in Alzheimer's disease patients (2009) (1)
- A Thoughtful Perspective on Atypical Parkinsonian Disorders (2006) (1)
- Ttp488 path to registration: Leveraging enrichment strategies (2015) (1)
- The 32-Item Multilingual Naming Test: Cultural and Linguistic Biases in Monolingual Chinese-Speaking Older Adults (2021) (1)
- Research Attitudes and Interest Among Elderly Latinxs: The Impact of a Collaborative Video and Community Peers. (2021) (1)
- Neurodegenerative Diseases: Treatment of Alzheimer's disease (2005) (1)
- Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19 (2021) (1)
- P3-285: Impact of APOE ϵ4 on very late life cognition (2008) (1)
- Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer DiseaseA Randomized Controlled Trial (2000) (1)
- ASSESSING CLINICAL PROGRESSION FOR DEMENTIA PREVENTION TRIAL: RESULTS FROM THE HBA TRIAL (2014) (1)
- Alzheimer's Disease Cooperative Study Prevention Instrument Project Assessing Resource Use and Volunteer and Paid Work in Healthy Elders: A Longitudinal Study (2014) (1)
- BEIJING VERSION OF THE MONTREAL COGNITIVE ASSESSMENT FOR ELDERLY CHINESE AMERICANS (2016) (1)
- Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
- Accessing health care finance administration beneficiaries as potential participants in a primary prevention trial for Alzheimer's disease (2000) (1)
- Willingness to participate in an Alzheimer's disease prevention trials among mild cognitively impaired elderly (2000) (1)
- A reliable standardized technique for dating the onset of Alzheimer's disease. (1992) (1)
- Assessing dependence, a unique feature of functional decline in Alzheimer's disease. (1992) (1)
- NEUROPSYCHIATRIC SYMPTOMS ARE ASSOCIATED WITH COGNITIVE FUNCTION IN ELDERLY WITH TYPE 2 DIABETES (2016) (1)
- Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium (2022) (1)
- Amyloid imaging for cognitive studies in cohorts with racial and ethnic diversity (2020) (1)
- CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease (2022) (1)
- The challenges of recruiting individuals with mild cognitive impairment (MCI) for biomarker studies in a veteran population (2015) (1)
- After the Diagnosis of Dementia: Considerations in Disease Management (2013) (1)
- Haptoglobin 1-1 Genotype Is AssociatedWith Poorer Cognitive Functioning in Type 2 Diabetic Elderly (2013) (1)
- Policy Forum 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (1)
- Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum] (2014) (1)
- Performance of Spanish-speaking community-dwelling elders in the U.S. on the Uniform Data Set (UDS) (2013) (1)
- The Absence of an Apolipoprotein E 4 Allele Is Associated with a More Aggressive Form of Alzheimer ' s Disease (2013) (1)
- TACRINE AND NURSING HOME PLACEMENT. AUTHORS' REPLY (1997) (1)
- Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force (2018) (1)
- Detection of mild cognitive impairment and early-stage dementia with an audio-recorded cognitive scale (2013) (1)
- Age and APOE genotype influence rate of cognitive decline in non-demented elderly (2013) (1)
- Longitudinal patterns of medication use in Alzheimer's disease (2010) (1)
- BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer’s disease mouse model (2022) (0)
- Estrogen in Alzheimer's disease: Treatment or prevention (2000) (0)
- P-081 The ACDS home assessment instrument: A pilot study (2007) (0)
- P1-003 ADCS Prevention instrument project: assessment of activities of daily living (ADL) (2004) (0)
- Clinical symptoms of dementia with Lewy bodies: Secondary analyses of the Alzheimer's disease cooperative study selegiline and vitamin E clinical trial (1999) (0)
- INCREASING INTEREST IN RESEARCH PARTICIPATION: EFFECTIVENESS OF A VIDEO AND PEER ROLE MODEL INTERVENTION WITH MINORITY SENIORS (2019) (0)
- MAPT haplotypes modify the association between head injury and risk of Alzheimer’s disease (2015) (0)
- Physical Activity Is Associated with Slower Cognitive Decline in Older Adults with Type 2 Diabetes (2023) (0)
- Effects of Oral Physostigmme in Alzheimer ’ s Disease (0)
- Safety and Tolerability of Dimebon for up to 26 Weeks in Patients With Mild to Moderate Alzheimer's Disease (2010) (0)
- O2-07-04 A CROSS-CULTURAL QUALITATIVE STUDY OF BARRIERS AND FACILITATORS TO GOOD QUALITY CARE FOR PEOPLE WITH DEMENTIA (2008) (0)
- Cross‐ancestry effect of APOE on cognitive performance (2022) (0)
- Neuropsychological Test Performance in Cognitively Normal Spanish-speaking Nonagenarians with Little Education (2016) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Operational criteria for patient recruitment in trials of mild cognitive impairment (2005) (0)
- O1-01-05 An association between cardiovascular risk and cognitive status in non-demented elderly women with a family history of Alzheimer’s disease (2007) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Connecting Cohorts to Diminish Alzheimer’s Disease (CONCORD-AD): A Report of an International Research Collaboration Network (2021) (0)
- Comparison of Cognitive Status, Psychopathology, and Functional Performance of Minority Older Adults with and Without Type 2 Diabetes (2018) (0)
- Prevention of Postmenopausal Alzheimer's Disease and Cognitive Loss with Replacement Estrogen (PREPARE) Study Results (2010) (0)
- Performance on ADAS-Cog items across ADCS trials (2012) (0)
- Specific affective dimensions are associated with a faster rate of cognitive decline in older adults (2021) (0)
- Extent and impact of missing ADAS-cog items in ADCS clinical trials (2011) (0)
- 1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France (2008) (0)
- P1-407 ADCS prevention instrument project: overview and initial results (2004) (0)
- PL-04-01 Caloric restriction (2006) (0)
- Reduction and Prevention of Agitation in Patients with Neurocognitive Disorders: An International Psychogeriatric Association Consensus Algorithm (2022) (0)
- Greater apathy is associated with faster rate of cognitive decline in older adults with type 2 diabetes (2020) (0)
- Developing outcome measures for therapeutic trials for dementia in aging individuals with Down Syndrome (2005) (0)
- Abstract Sixteenth annual meeting of the society for clinical trialP44 Implementation of multicenter clinical trials: The Alzheimer's Disease Cooperative Study protocol implementation manual (1995) (0)
- A34 Clinical monitoring of rating scales in multicenter clinical trials (1996) (0)
- OLDER VETERANS WITH TYPE 2 DIABETES: A1C AND COGNITIVE FUNCTION (2017) (0)
- Measuring cognitive progression in Alzheimer's disease (1998) (0)
- Clinical versus neuropathological diagnosis in an ADRC sample: Factors impacting diagnostic concordance rates (2020) (0)
- Racial/ethnic disparities in initiation and persistent use of anti‐dementia medications (2022) (0)
- CO160 Dependence Levels Derived From the Alzheimer's Disease Cooperative Study – Activities of Daily Living in People With Early (Prodromal-to-Mild) Alzheimer's Disease (2022) (0)
- Racial/ethnic disparities in new and persistent cholinesterase inhibitors treatment in Alzheimer’s disease (2021) (0)
- Socio‐psychological impact of COVID‐19 on a diverse cohort of older adult research participants in New York (2021) (0)
- Subjective cognitive complaints in Chinese‐ and English‐speaking older adults (2021) (0)
- TAU IMAGING WITH [18F]T807/AV-1451 IN ATHLETES WITH POST-CONCUSSIVE COMPLAINT AND CONTROLS (2017) (0)
- Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study (2021) (0)
- Smartphone ownership and usage in Chinese‐ and English‐speaking older adults (2021) (0)
- EXPLORING A ROLE FOR MICRORNA195 (MIR195) AS A POTENTIAL ALZHEIMER’S DISEASE BIOMARKER (2019) (0)
- Predicting Conversions from Normal to MCI and from MCI to AD with Clinical Variables in the National Alzheimer’s Coordinating Center Uniform Data Set Version 3: Application of Big Data Analytics and Transition Probability Calculators (2022) (0)
- Case Report: A World Trade Center (WTC) responder presenting with moderate stage dementia by age 57, suggesting an extended severity of WTC-associated illness' (2021) (0)
- evoke and evoke+: design of two large‐scale, double‐blind, placebo‐controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer’s disease (2022) (0)
- AGING AND MENTAL HEALTH: FROM SYNAPSE TO COMMUNITY (2014) (0)
- Utilizing study and site performance metrics to improve efficiency of clinical trials: An initiative of the Alzheimer’s Clinical Trials Consortium (ACTC) (2021) (0)
- Perspectives Priorities for research consortia on Alzheimer's disease (2010) (0)
- Mild behavioral impairment checklist differentiates normal controls and MCI in a well‐characterized sample (2020) (0)
- LONGITUDINAL EFFECTS OF DIABETES ON COGNITIVE DECLINE: RESULTS FROM THE NATIONAL ALZHEIMER'S COORDINATING CENTER'S UNIFORM DATA SET (NACC UDS) (2016) (0)
- Evaluating memory testing to distinguish dementia severity among White, Black, and Spanish-speaking individuals in the Uniform Data Set (UDS). (2023) (0)
- Specific depression dimensions are associated with a faster rate of cognitive decline in older adults (2022) (0)
- Longitudinal characterization of mild cognitive impairment and dementia in World Trade Center responders at midlife (2021) (0)
- International Psychogeriatric Association (IPA): Topics in Aging and Mental Health (2020) (0)
- Defining agitation, apathy and other psychiatric symptoms in cognitive impairment and dementia: Why we need to intervene (2020) (0)
- Cognitive Health in the Postmenopausal Woman This work was supported by Federal Grants AG 15922. (2007) (0)
- International Psychogeriatric Association Psychosis Survey (2020) (0)
- A health education based on a health screening examination in a company (1997) (0)
- Serum Advanced Glycation Endproducts (AGE) Correlate With Cognition in the Very Elderly (2006) (0)
- How can geriatric psychiatry professional organizations maximize multidisciplinary partnerships to advance care? (2022) (0)
- Web-based screening, data entry and data management in Alzheimer's disease research (2000) (0)
- Issues of Female Physiology and Reproductive Responses in the Neurorehabilitation Setting (1997) (0)
- 102 - IPA Guidelines on Dementia and Agitation: From Provisional to Final (2021) (0)
- A logistic mortality risk model for seropositive gay men with neurological manifestations. (1992) (0)
- THE HAPTOGLOBIN 1-1 GENOTYPE IS ASSOCIATED WITH COGNITIVE FUNCTION AND DECLINE IN AFRICAN AMERICAN PERSONS WITH TYPE 2 DIABETES: THE ACCORD-MIND STUDY (2018) (0)
- Never Too Fit for Body and Mind (2013) (0)
- Neuropsychological characteristics of weclinical dementia in A Parkinson ’ s disease (0)
- Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer’s Disease (2019) (0)
- Role of caregiver in subject's compliance with treatment (2011) (0)
- P3-161: In-person versus telephone administration of a neuropsychological battery for an elderly cohort (2008) (0)
- Alzheimer's disease after remoteheadinjury: an incidence study (1997) (0)
- Response to Schneider and Goldberg “Composite cognitive and functional measures for early stage Alzheimer's disease trials” (2020) (0)
- International Psychogeriatric Association (IPA) consensus for defining psychosis in major and mild neurocognitive disorders. (2021) (0)
- Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool (2022) (0)
- Using family history to enrich recruitment in prevention trials: Does relative’s age matter? (2005) (0)
- Assessing Health Related Resource use in Normal Elders and Subjects With Mild Cognitive Impairment (2010) (0)
- Colloquium C04: Estrogen and Neurodegenerative Diseases: A Protective Role? (2003) (0)
- REVISING THE ADMINISTRATION OF THE ADAS-COG (2014) (0)
- Reply from the Authors (1997) (0)
- P4-387: Adding delayed recall to the Alzheimer's disease assessment scale–cognitive subscale (ADAS-cog): Sensitivity in a clinical trial for Alzheimer's disease and mild cognitive impairment (2008) (0)
- Age, gender and education are associated with cognitive performance in among Israeli elderly individuals with type 2 diabetes (2013) (0)
- THE RELATIONSHIP OF DEPRESSIVE SYMPTOMS WITH COGNITIVE FUNCTION IS DIFFERENT FOR MEN AND WOMEN WITH TYPE 2 DIABETES (2016) (0)
- Apathy and Functional Impairment in the Course of Behavioral Variant Frontotemporal Dementia (2022) (0)
- Abstracts of the 16th International Congress: Towards Successful Aging: Harmony of Mental, Physical and Social Life, 1–4 October 2013,Seoul, Korea. (2013) (0)
- P3-442: Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies (2008) (0)
- Self and proxy ratings of patient-reported outcomes: Impact of cognitive status (2013) (0)
- Consensus provisional definition of agitation in cognitive disorders (2019) (0)
- Orally active mGluR2/3 metabotropic antagonist pro-drug mimics the beneficial effects of physical exercise on neurogenesis, behavior, and exercise-related molecular pathways in an Alzheimer’s disease mouse model (2022) (0)
- Principles of the Pharmacotherapy of Dementia (2011) (0)
- Florbetapir F18 Positron Emission Tomography Identification of beta-Amyloid in the Living Brain: A Consecutive Clinical Case Series (P6.319) (2014) (0)
- P3-120 Predictors of dropout in clinical trials of subjects with mild cognitive impairment (MCI) (2006) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- P1-214 Advanced glycation is associated with cognitive impairment in very old women (2006) (0)
- MAILING OUTREACH FOR PARTICIPATION IN COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE RESEARCH (2019) (0)
- P1-169 Clinical and neuropathologic studies of age-related cognitive loss in Mumbai, India (2006) (0)
- P2-607 DEPRESSIVE SYMPTOMS PREDICT COGNITIVE DECLINE IN OLDER ADULTS (2018) (0)
- Why they stay: Understanding participant retention in Alzheimer's disease research (2013) (0)
- O2-07-05: Patient dependence, function, and changes in cost of care in Alzheimer's disease (2008) (0)
- Neuropsychological Testing Identifies Patients with Pathologic Levels of β-Amyloid in the Living Brain as Demonstrated by Florbetapir F18 Positron Emission Tomography (P07.141) (2013) (0)
- Depression and the apathy symptom are associated with poorer cognitive functioning in very old men (2020) (0)
- Dementia and Other Neurocognitive Disorders (2016) (0)
- Attitudes toward research in an urban minority population: A pilot study (2013) (0)
- Additional file 6: Table S6. of Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimerâ s disease: post-hoc analysis of a randomized placebo-controlled study (2016) (0)
- P2–358: Withdrawn (2013) (0)
- Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes (2018) (0)
- Treatment of Alzheimer's Disease (With or Without Cerebrovascular Disease) (2008) (0)
- Adjudicating Mild Cognitive Impairment Due to Alzheimer’s Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial (2021) (0)
- Non-Amyloid Approaches to Neuroprotection (2008) (0)
- P1-206 The search for a successful cognitive aging endophenotype in the offspring of very elderly (90+) nondemented probands in a founder population (2006) (0)
- Title Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease : A randomized controlled trial Permalink (2000) (0)
- S3-02-03 Results of a one-year randomized, placebo-controlled trial of dimebon for the treatment of mild to moderate Alzheimer’s disease (2007) (0)
- Alzheimer's disease and chronic traumatic encephalopathy: An overlapping pathological picture? (2010) (0)
- P1-381: Pilot study to assess reliability and efficiency of home-based assessment for dementia prevention trials (2008) (0)
- Current Therapies for Alzheimer’s Disease (2013) (0)
- Title Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer ’ s disease (2000) (0)
- High-Dose B Vitamin Supplements and Alzheimer Disease—Reply (2009) (0)
- P4-363: A randomized clinical trial of vitamin E and memantine in Alzheimer's disease (2008) (0)
- Advancing Alzheimer's Diagnosis, Treatment and Care: Recommendations from the Ware Invitational Summit (2013) (0)
- Onset and duration of symptoms in mild cognitive impairment (2000) (0)
- ALZ‐NET: Using Real World Evidence to Inform the Future of Alzheimer’s Treatment and Care (2022) (0)
- Attitudes towards memory research participation: Focus groups with elderly African Americans viewing a community‐created educational video (2020) (0)
- P1-122 ADCS prevention instrument project: pharmacoeconomic assessment: resource use instrument (RUI) for healthy elderly (2004) (0)
- Alzheimer's Disease: An Overview of Clinical Presentation, Treatment, and Research (2005) (0)
- Natural history of apathy in Alzheimer’s disease (2020) (0)
- RESEARCH SATISFACTION IN ALZHEIMER’S TRIALS AND STUDIES AMONG PARTICIPANTS AND STUDY PARTNERS (2017) (0)
- Mail and Telephone Outreach from Electronic Health Records for Research Participation on Cognitive Health and Aging (2021) (0)
- Enhancing underrepresented group participation in aging research through workforce development of the Community Research Liaison (2021) (0)
- Investigating changes in fluid biomarkers in early Alzheimer’s disease: design of plasma biomarker analyses and a cerebrospinal fluid sub‐study in the evoke and evoke+ trials of semaglutide versus placebo (2022) (0)
- CONCORDE-AD: AN INTERNATIONAL NETWORK OF COHORTS FOR BETTER UNDERSTANDING OF ALZHEIMER’S DISEASE (2018) (0)
- 103 - A global perspective on dignity-based psychogeriatric care: An urgent call for a Convention on rights for older people (2021) (0)
- Ethnicity/culture modulates the relationships of the haptoblobin (Hp) 1-1 phenotype with cognitive function in elderly with type 2 diabetes (2015) (0)
- Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife (2022) (0)
- Cognitive Effects of A typical A ntipsychotic M ed ications in Patients (0)
- Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study (2016) (0)
- Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community (2020) (0)
- The Nairobi Declaration—Reducing the burden of dementia in low‐ and middle‐income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs (2023) (0)
- Florbetapir F18 PET identification of beta-amyloid in the living brain: A consecutive clinical case series (2013) (0)
- Hormone Replacement Therapy and Cognitive Function (2010) (0)
- THE UTILITY OF VERBAL MEMORY TESTS AS SENSITIVE MARKERS FOR EARLY-STAGE ALZHEIMER’S DISEASE IN ELDERLY CHINESE AMERICANS (2019) (0)
- Reply from the Authors (1997) (0)
- DEPRESSIVE SYMPTOMS PREDICT COGNITIVE DECLINE IN OLDER ADULTS (2018) (0)
- Oligomeric abeta associated with dementia in young-old and oldest-old persons (2011) (0)
- “MEMORY RESEARCH: IS IT RIGHT FOR ME?” A VIDEO/PEER ROLE MODEL INTERVENTION TO CHANGE RESEARCH ATTITUDES AMONG ELDERLY MINORITIES (2019) (0)
- Evaluating participant and coordinator satisfaction with telephone assessments (2021) (0)
- Vitamin E and Other Antioxidant Treatments for the Neurobehavioral Aspects of Alzheimer’s Disease and Other Neurodegenerative Disorders (2000) (0)
- 413 - Telehealth in Multiethnic Caregiver Support Group: Transition from Telephone to Video in the Age of COVID-19 (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mary C. Sano?
Mary C. Sano is affiliated with the following schools:
